53.035  -1.835 (-3.34%)		07-10 15:59
Open: 53.635 High: 53.635 Volume: 40,231		Pre. Close: 54.87 Low: 51.8 Market Cap: 56(M)

Short term
Mid term
Targets	6-month :	64.08	1-year :	74.85
Resists	First :	54.86	Second :	64.08
Pivot price	51.24
Supports	First :	45.69	Second :	40.02
MAs	MA(5) :	53.56	MA(20) :	49.27
	MA(100) :	44.16	MA(250) :	36.19
MACD	MACD :	2.6	Signal :	2.3
%K %D	K(14,3) :	89.8	D(3) :	92.5
RSI	RSI(14): 64.2
52-week	High :	54.86	Low :	20.52

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ BBC ] has closed below upper band by 32.3%. Bollinger Bands are 66.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 13 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	53.71 - 53.98	53.98 - 54.21
Low:	51.18 - 51.47	51.47 - 51.7
Close:	52.61 - 53.06	53.06 - 53.43

This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

Sun, 05 Jul 2026
Trading the Move, Not the Narrative: (BBC) Edition - Stock Traders Daily

Tue, 30 Jun 2026
Biotech ETF (BBC) Touches a New 52-Week High - Yahoo Finance

Sat, 13 Jun 2026
Price-Driven Insight from (BBC) for Rule-Based Strategy - Stock Traders Daily

Tue, 02 Jun 2026
(BBC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Fri, 10 Apr 2026
Biotech ETF (BBC) Touches Fresh 52-Week High - Yahoo Finance

Thu, 15 Jun 2023
Virtus LifeSci Biotech Clinical Trials ETF Review and Aggregate Rating (BBC) $BBC - MarketBeat

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.